Richards, Merrill & Peterson, Inc. Eli Lilly & CO Transaction History
Richards, Merrill & Peterson, Inc.
- $192 Billion
- Q1 2025
A detailed history of Richards, Merrill & Peterson, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Richards, Merrill & Peterson, Inc. holds 611 shares of LLY stock, worth $483,447. This represents 0.26% of its overall portfolio holdings.
Number of Shares
611
Previous 568
7.57%
Holding current value
$483,447
Previous $438 Million
15.09%
% of portfolio
0.26%
Previous 0.23%
Shares
2 transactions
Others Institutions Holding LLY
# of Institutions
4,394Shares Held
821MCall Options Held
10MPut Options Held
10.8M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$80.2 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$76 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$62.7 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$52.1 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$27.2 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $752B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...